Professor Susan Cohn, Clinical Sciences, the Institute for Molecular Pediatric Sciences,
University of Illinois, Chicago. Dr. Cohn's research interests are focused on understanding the biology of neuroblastoma, a clinically heterogeneous childhood cancer, and identifying new potential therapeutic targets. One research project ongoing in Dr. Cohn's laboratory involves the analysis of angiogenesis in neuroblastoma. Dr. Cohn's laboratory was the first to report the correlations between high vascular density in neuroblastoma tumors and advanced stage disease, unfavorable histology, MYCN amplification, and poor outcome. |
|
Dr. Anthony Michalski, PhD MB MRCP FRCPCH, Senior Consultant, Department of Hematology/ Oncology, The Hospital for Sick Children, Great Ormond Street, London.
Dr Michalski is a child oncologist at the UK's biggest children's cancer unit - where the treatments are considered among the best in the world. He specialises in solid tumours, brain tumours in particular, and works as part of a close-knit team to provide both physical and psychological care. (The photo is from a previous meeting in Tromsö.) |
|
Professor Robert W. Butler, Division of Pediatric Hematology/Oncology, Oregon Health & Science University, Portland, Oregon.
The focus of Dr. Butler's clinical interests are clinical neuropsychology, brain injury rehabilitation and hypnosis. |